P53 and ARF: Unexpected players in autophagy

Trends in Cell Biology

Volumn 20, Issue 6, 2010, Pages 363-369

  Balaburski, Gregor M ^a   Hontz, Robert D ^a   Murphy, Maureen E ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARF PROTEIN; AUTOPHAGY PROTEIN 5; AUTOPHAGY PROTEIN 7; BECLIN 1; CYCLIN DEPENDENT KINASE INHIBITOR 2A; GENE PRODUCT; MITOCHONDRIAL PROTEIN; PROTEIN DRAM; PROTEIN P53; UNCLASSIFIED DRUG;

AUTOPHAGY; CARCINOGENESIS; CELL SURVIVAL; GENE REPRESSION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; STRESS; TRANSACTIVATION; TRANSCRIPTION REGULATION; TUMOR GROWTH; UPREGULATION;

ANIMALS; AUTOPHAGY; CYCLIN-DEPENDENT KINASE INHIBITOR P16; HUMANS; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53;

EUKARYOTA;

EID: 77953621745     PISSN: 09628924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcb.2010.02.007     Document Type: Review

References (67)

1. Vousden K.H., Prives C. Blinded by the light: the growing complexity of p53. Cell 2009, 137:413-431.
2. Eischen C.M., et al. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev. 1999, 13:2658-2669.
3. Robertson K.D., Jones P.A. The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53. Mol. Cell Biol. 1998, 18:6457-6473.
4. Stott F.J., et al. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 1998, 17:5001-5014.
5. Esclatine A., et al. Macroautophagy signaling and regulation. Curr. Top. Microbiol. Immunol. 2009, 335:33-70.
6. Yang Z., Klionsky D.J. An overview of the molecular mechanism of autophagy. Curr. Top. Microbiol. Immunol. 2009, 335:1-32.
7. Komatsu M., et al. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J. Cell Biol. 2005, 169:425-434.
8. Kuma A., et al. The role of autophagy during the early neonatal starvation period. Nature 2004, 432:1032-1036.
9. Liang X.H., et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999, 402:672-676.
10. Aita V.M., et al. Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics 1999, 59:59-65.
11. Liang C., et al. Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nat. Cell Biol. 2006, 8:688-699.
12. Takahashi Y., et al. Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis. Nat. Cell Biol. 2007, 9:1142-1151.
13. Karantza-Wadsworth V., et al. Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev. 2007, 21:1621-1635.
14. Mathew R., et al. Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev. 2007, 21:1367-1381.
15. Mathew R., et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell 2009, 137:1062-1075.
16. Young A.R., et al. Autophagy mediates the mitotic senescence transition. Genes Dev. 2009, 23:798-803.
17. Crighton D., et al. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 2006, 126:121-134.
18. Amaravadi R.K., et al. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J. Clin. Invest. 2007, 117:326-336.
19. Carew J.S., et al. Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance. Blood 2007, 110:313-322.
20. Maclean K.H., et al. Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis. J. Clin. Invest. 2008, 118:79-88.
21. Feng Z., et al. The coordinate regulation of the p53 and mTOR pathways in cells. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:8204-8209.
22. Jones R.G., et al. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol. Cell 2005, 18:283-293.
23. Feng Z., et al. The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways. Cancer Res. 2007, 67:3043-3053.
24. Budanov A.V., Karin M. p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell 2008, 134:451-460.
25. 2-terminal kinase activation is essential for DRAM-dependent induction of autophagy and apoptosis in 2-methoxyestradiol-treated Ewing sarcoma cells. Cancer Res. 2009, 69:6924-6931.
26. Crighton D., et al. p73 regulates DRAM-independent autophagy that does not contribute to programmed cell death. Cell Death Differ. 2007, 14:1071-1079.
27. Rosenbluth J.M., et al. A gene signature-based approach identifies mTOR as a regulator of p73. Mol. Cell Biol. 2008, 28:5951-5964.
28. Buzzai M., et al. Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth. Cancer Res. 2007, 67:6745-6752.
29. Evans J.M., et al. Metformin and reduced risk of cancer in diabetic patients. BMJ 2005, 330:1304-1305.
30. Tasdemir E., et al. A dual role of p53 in the control of autophagy. Autophagy 2008, 4:810-814.
31. Tasdemir E., et al. Regulation of autophagy by cytoplasmic p53. Nat. Cell Biol. 2008, 10:676-687.
32. Tasdemir E., et al. p53 represses autophagy in a cell cycle-dependent fashion. Cell Cycle 2008, 7:3006-3011.
33. Donehower L.A. Does p53 affect organismal aging?. J. Cell. Physiol. 2002, 192:23-33.
34. Tavernarakis N., et al. The effects of p53 on whole organism longevity are mediated by autophagy. Autophagy 2008, 4:870-873.
35. Morselli E., et al. Mutant p53 protein localized in the cytoplasm inhibits autophagy. Cell Cycle 2008, 7:3056-3061.
36. Reef S., et al. A short mitochondrial form of p19ARF induces autophagy and caspase-independent cell death. Mol. Cell 2006, 22:463-475.
37. Itahana K., Zhang Y. Mitochondrial p32 is a critical mediator of ARF-induced apoptosis. Cancer Cell 2008, 13:542-553.
38. Reef S., et al. The autophagic inducer smARF interacts with and is stabilized by the mitochondrial p32 protein. Oncogene 2007, 26:6677-6683.
39. Ueda Y., et al. Small mitochondrial ARF (smARF) is located in both the nucleus and cytoplasm, induces cell death, and activates p53 in mouse fibroblasts. FEBS Lett. 2008, 582:1459-1464.
40. Abida W.M., Gu W. p53-Dependent and p53-independent activation of autophagy by ARF. Cancer Res. 2008, 68:352-357.
41. Reef S., Kimchi A. Nucleolar p19ARF, unlike mitochondrial smARF, is incapable of inducing p53-independent autophagy. Autophagy 2008, 4:866-869.
42. Humbey O., et al. The ARF tumor suppressor can promote the progression of some tumors. Cancer Res. 2008, 68:9608-9613.
43. Geradts J., et al. Immunohistochemical detection of the alternate INK4a-encoded tumor suppressor protein p14(ARF) in archival human cancers and cell lines using commercial antibodies: correlation with p16(INK4a) expression. Mod. Pathol. 2001, 14:1162-1168.
44. Sherr C.J., et al. p53-Dependent and -independent functions of the Arf tumor suppressor. Cold Spring Harb. Symp. Quant. Biol. 2005, 70:129-137.
45. Chen Z., et al. Differential p53-independent outcomes of p19(Arf) loss in oncogenesis. Sci. Signal 2009, 2:ra44.
46. Pimkina J., Murphy M.E. ARF, autophagy and tumor suppression. Autophagy 2009, 5:397-399.
47. Pimkina J., et al. ARF induces autophagy by virtue of interaction with Bcl-xl. J. Biol. Chem. 2009, 284:2803-2810.
48. Maiuri M.C., et al. Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J. 2007, 26:2527-2539.
49. Pattingre S., et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005, 122:927-939.
50. Yee K.S., et al. PUMA- and Bax-induced autophagy contributes to apoptosis. Cell Death Differ. 2009, 16:1135-1145.
51. Bensaad K., et al. Modulation of intracellular ROS levels by TIGAR controls autophagy. EMBO J. 2009, 28:3015-3026.
52. Kirkegaard, T. et al. (2010) Hsp70 stabilizes lysosomes and reverts Niemann-Pick disease-associated lysosomal pathology. Nature 463, 549-553.
53. Nylandsted J., et al. Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization. J. Exp. Med. 2004, 200:425-435.
54. Leu J.I., et al. A small molecule inhibitor of inducible heat shock protein 70. Mol. Cell 2009, 36:15-27.
55. Degenhardt K., et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 2006, 10:51-64.
56. Tasdemir E., et al. Cell cycle-dependent induction of autophagy, mitophagy and reticulophagy. Cell Cycle 2007, 6:2263-2267.
57. Levine B., et al. Bcl-2 family members: dual regulators of apoptosis and autophagy. Autophagy 2008, 4:600-606.
58. Solomon V.R., Lee H. Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies. Eur. J. Pharmacol. 2009, 625:220-233.
59. Belanger M., et al. Autophagy: a highway for Porphyromonas gingivalis in endothelial cells. Autophagy 2006, 2:165-170.
60. Blommaart E.F., et al. The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes. Eur. J. Biochem. 1997, 243:240-246.
61. Seglen P.O., Gordon P.B. 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proc. Natl. Acad. Sci. U. S. A. 1982, 79:1889-1892.
62. Abedin M.J., et al. Autophagy delays apoptotic death in breast cancer cells following DNA damage. Cell Death Differ. 2007, 14:500-510.
63. Hartford C.M., Ratain M.J. Rapamycin: something old, something new, sometimes borrowed and now renewed. Clin. Pharmacol. Ther. 2007, 82:381-388.
64. Martinet W., et al. Everolimus-induced mTOR inhibition selectively depletes macrophages in atherosclerotic plaques by autophagy. Autophagy 2007, 3:241-244.
65. Cao C., et al. Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells. Cancer Res. 2006, 66:10040-10047.
66. Yazbeck V.Y., et al. Temsirolimus downregulates p21 without altering cyclin D1 expression and induces autophagy and synergizes with vorinostat in mantle cell lymphoma. Exp. Hematol. 2008, 36:443-450.
67. Narita M., Young A.R. Autophagy facilitates oncogene-induced senescence. Autophagy 2009, 5:1046-1047.